Skip to content

Sodium Nitrate to Improve Blood Flow

Sodium Nitrate to Improve Blood Flow

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02847975
Enrollment
11
Registered
2016-07-28
Start date
2013-10-31
Completion date
2014-12-31
Last updated
2018-08-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Becker Muscular Dystrophy

Keywords

Becker, dystrophy, sympatholysis

Brief summary

Investigators recently showed that tadalafil restores functional sympatholysis in patients with Becker muscular dystrophy (BMD). If tadalafil restores functional sympatholysis in BMD via the NO-cyclic guanosine monophosphate pathway, then functional sympatholysis should also be restored by sodium nitrite- which is an indirect nitric oxide donor.

Interventions

DIETARY_SUPPLEMENTSodium nitrate

Sodium nitrate will be ingested orally

Sponsors

Cedars-Sinai Medical Center
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
MALE
Age
15 Years to 55 Years
Healthy volunteers
Yes

Inclusion criteria

* Becker muscular dystrophy * age 15-55 years of age * ambulatory

Exclusion criteria

* hypertension, diabetes, or heart failure by standard clinical criteria * elevated brain natriuretic peptide level (\>100 pg/ml) * Left ventricular ejection fraction \< 50% * cardiac rhythm disorder, specifically: rhythm other than sinus, supraventricular tachycardia, atrial fibrillation, ventricular tachycardia, heart block * continuous ventilatory support * liver disease * renal impairment * history of asthma or bronchospasm * use of any medications other than common supplements * unable to perform handgrip exercise

Design outcomes

Primary

MeasureTime frameDescription
change in muscle tissue oxygenationchange from baseline to post treatment (3-4 hours)The pre-specified primary outcome is the pre vs. post treatment change in functional sympatholysis measured by muscle oxygenation.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026